Alnylam Pharmaceuticals Inc (ALNY)
243.25
+0.99
(+0.41%)
USD |
NASDAQ |
Dec 24, 16:00
Alnylam Pharmaceuticals Free Cash Flow: 16.06M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc | 8.227B |
| BridgeBio Pharma Inc | -456.32M |
| Gilead Sciences Inc | 9.431B |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Sarepta Therapeutics Inc | -480.40M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 43.71M |
| Cash from Investing (Quarterly) | -30.25M |
| Cash from Financing (Quarterly) | 102.76M |
| Free Cash Flow Per Share (Quarterly) | 0.3073 |
| Free Cash Flow to Equity (Quarterly) | 38.55M |
| Free Cash Flow to Firm (Quarterly) | 41.80M |
| Free Cash Flow Yield | 0.05% |